| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
208,785,000 |
| Market
Cap: |
47.84(B) |
| Last
Volume: |
1,348,221 |
Avg
Vol: |
0 |
| 52
Week Range: |
$177.16 - $259.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 785 |
| Guru Rank Value : 1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile IQVIA Holdings is a provider of analytics, technology solutions, and clinical research services to the life sciences industry. Co. is managed through three reportable segments: Technology and Analytics Solutions, which provides information, technology solutions and real-world insights and services to its life science clients; Research and Development Solutions, which primarily serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services; and Contract Sales and Medical Solutions, which provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the healthcare market.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
68,853 |
81,970 |
115,108 |
120,554 |
| Total Sell Value |
$17,072,068 |
$19,879,540 |
$26,755,079 |
$27,988,147 |
| Total People Sold |
4 |
4 |
5 |
5 |
| Total Sell Transactions |
5 |
6 |
9 |
11 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Knightly Kevin C |
See Remarks |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
11,806 |
11,806 |
|
- |
|
| Korakis Emmanuel N |
Sr. Vice President, Controller |
• – – |
2021-02-09 |
4 |
D |
$183.82 |
$103,858 |
D/D |
(565) |
3,282 |
|
- |
|
| Korakis Emmanuel N |
Sr. Vice President, Controller |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,242 |
3,847 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2021-02-02 |
4 |
D |
$184.41 |
$11,345,272 |
D/D |
(61,522) |
590,513 |
|
- |
|
| Danhakl John G |
Director |
– • – |
2020-12-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
100,000 |
37,410 |
|
- |
|
| Danhakl John G |
Director |
– • – |
2020-12-23 |
4 |
B |
$176.95 |
$11,227,654 |
I/I |
63,451 |
137,410 |
2.1 |
32% |
|
| Rittenmeyer Ronald A |
Director |
– • – |
2020-11-24 |
4 |
S |
$172.96 |
$1,658,686 |
D/D |
(9,590) |
11,894 |
|
-17% |
|
| Rittenmeyer Ronald A |
Director |
– • – |
2020-11-16 |
4 |
S |
$174.35 |
$7,112,085 |
D/D |
(40,792) |
21,484 |
|
-10% |
|
| Korakis Emmanuel N |
Sr. Vice President, Controller |
• – – |
2020-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,605 |
1,605 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-10-12 |
4 |
AS |
$170.00 |
$11,750,400 |
D/D |
(69,120) |
652,035 |
|
12% |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-10-12 |
4 |
A |
$8.34 |
$576,461 |
D/D |
69,120 |
721,155 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-09-15 |
4 |
AS |
$164.36 |
$7,573,709 |
D/D |
(46,080) |
652,035 |
|
5% |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-09-15 |
4 |
A |
$8.34 |
$384,307 |
D/D |
46,080 |
698,115 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-08-14 |
4 |
AS |
$161.66 |
$11,173,939 |
D/D |
(69,120) |
652,035 |
|
9% |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-08-14 |
4 |
A |
$8.34 |
$576,461 |
D/D |
69,120 |
721,155 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2020-08-07 |
4 |
D |
$160.54 |
$2,170,982 |
D/D |
(13,523) |
12,470 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2020-08-07 |
4 |
S |
$160.04 |
$3,265,332 |
D/D |
(20,367) |
25,993 |
|
-12% |
|
| Staub W Richard |
See Remarks |
• – – |
2020-08-07 |
4 |
OE |
$53.26 |
$2,955,127 |
D/D |
33,890 |
32,877 |
|
- |
|
| Bruehlman Ronald E |
See Remarks |
• – – |
2020-08-04 |
4 |
B |
$159.94 |
$1,599,400 |
D/D |
10,000 |
26,751 |
2.74 |
8% |
|
| Bruehlman Ronald E |
See Remarks |
• – – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
16,751 |
16,751 |
|
- |
|
| Bruehlman Ronald E |
See RemarksOfficer |
• – – |
2020-08-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
| Coulter James G |
Former Director |
– – – |
2020-07-28 |
4 |
S |
$159.12 |
$464,479,395 |
I/I |
(2,919,051) |
0 |
|
-8% |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-07-22 |
4 |
AS |
$160.00 |
$7,372,800 |
D/D |
(46,080) |
652,035 |
|
4% |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-07-22 |
4 |
A |
$8.34 |
$384,307 |
D/D |
46,080 |
698,115 |
|
- |
|
| Mcdonnell Michael R |
EVP and CFO |
• – – |
2020-07-05 |
4 |
D |
$141.52 |
$390,878 |
D/D |
(2,762) |
18,966 |
|
- |
|
490 Records found
|
|
Page 6 of 20 |
|
|
2.10 (0.92%) 
